Notably, the CCR5 antagonist maraviroc, which inhibits CCR5, has been linked to the repolarization of tumor-associated macrophages, emerging as a promising avenue for further scientific and clinical exploration.355. The gene discussed is CCR5; the disease is neoplasm.